-
Pembrolizumab trumps chemotherapy in recurrent head and neck cancer
pharmaceutical-technology
June 05, 2019
Research has shown that immunotherapy pembrolizumab alone and in combination with chemotherapy is a more efficacious first line treatment for head and neck cancer that has returned than aggressive chemotherapy.
-
Health Tip: Understanding Liver Spots
drugs
June 05, 2019
Understanding Liver Spots.
-
Is MRI Screening Worth It for Breast Cancer Survivors?
drugs
June 05, 2019
Breast MRI screening is a good way to detect small tumors, but it's unclear how much it benefits women with a history of breast cancer, a new study finds.
-
Testicular Cancer Treatment Unlikely to Trigger Birth Defects
drugs
June 05, 2019
Testicular Cancer Treatment Unlikely to Trigger Birth Defects.
-
ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer
drugs
June 05, 2019
Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer.
-
ASCO: Survival Up With Ribociclib in Advanced Breast Cancer
drugs
June 05, 2019
Survival Up With Ribociclib in Advanced Breast Cancer.
-
Higher Surgical Volume May Improve Outcomes in Cervical Cancer
drugs
June 04, 2019
Higher Surgical Volume May Improve Outcomes in Cervical Cancer.
-
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer
drugs
June 04, 2019
Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer.
-
Guidelines Updated for Radiotherapy After Prostatectomy
drugs
June 03, 2019
Guidelines Updated for Radiotherapy After Prostatectomy.
-
SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer
b3cnewswire
June 03, 2019
SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer.